| The Relationship Between Main Blood Groups in Clinical and Paraclinical Findings and Final Outcome of Hospitalized Patients with COVID-19 | 
								
								  |  | 
								
								  |  | 
								
								  |  | 
                                
								  | Abstract:       (1469 Views) | 
								
								  | Introduction: It is essential to identify the crucial factors in the prognosis of patients with COVID-19. This study aimed to evaluate the relationship between the main blood groups in clinical and paraclinical and outcome of patients with COVID-19. Methods: This descriptive-cross-sectional study was conducted in 2021 in Be’sat Hospital in Tehran, Iran. In this study, patients hospitalized with COVID-19 were examined for their blood groups and Rh through five CC of peripheral blood sample, and the clinical and paraclinical findings of the patients were analyzed using Chi-square, Fisher, and t-test by SPSS-24 software. This study was approved by the ethical code number: IR.AJAUMS.REC.1399.227.
 Finding: People with blood group B and RH negative had a younger age for hospitalization. The frequency of fever, weakness, cough, chest pain, dyspnea, serum ferritin level, and the mortality rate in blood group A was higher than other blood groups. RH+ patients also had higher cough, nausea, vomiting, chest pain and serum D-Dimer levels.
 Conclusion: Blood group A is associated with an increased risk of developing COVID-19, especially severe disease
 | 
								
								  | Article number: 1 | 
								
								  | Keywords:  Covid-19, Blood group, Rh, Dyspnea, Mortality, Ferritin, D-Dimer | 
								
								  |  | 
								
								  | Full-Text  [PDF 278 kb] 
                                    
                                     
                                     
                                    
									  
                                       (406 Downloads) | 
								
								  | Type of Study:  مقاله ترجمه |
                                  Subject: 
                                  Special Received: 2024/09/21 | Accepted: 2024/09/22 | Published: 2024/09/22
 | 
                                
                                  
                                    |  | 
								
								  |  | 
								
								  |  | 
								
								  |  | 
								
								  | Add your comments about this article | 
                                
                                |  | 
								
								  |  |